Notable Guests
Recent Episodes
✨
Professor Iain McInnes discusses BMI's impact on JAK inhibitor response in RA.
✨
BE MOBILE trials analyzed 52-week data on bimekizumab for axSpA.
✨
Discussing long-term methotrexate durability for RA risk.
✨
Reviewing biologic effectiveness and treatment persistence in RA.
✨
Discussing minimal clinically important improvement thresholds in PsA.
✨
Examining shared epitope influence on RA biologic effectiveness.
✨
Analyzing long-term outcomes of advanced RA therapies.
✨
Discussing a trial comparing ixekizumab with tirzepatide vs. ixekizumab alone.
✨
Reviewing top axSpA publications.
✨
Discussing axial involvement in psoriatic arthritis.
✨
Reviewing infectious complications of RA treatments.
✨
Discussing malignancy risk in RA patients.
Chung-Mao Kao
✨
Exploring personalized treatment targets in PsA.
✨
Reviewing top abstracts from EULAR 2026.
0:04:51
0:03:27
0:05:33